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Abstract Freshly enzymatically isolated pancreatic acini from
lactating and weaning Wistar rats were used to investigate the
role of protein kinase C (PKC) isoforms during these physiolog-
ically relevant pancreatic secretory and growth processes. The
combination of immunoblot and immunohistochemical analysis
shows that the PKC isoforms K, N, and O are present in
pancreatic acini from control, lactating and weaning rats. A
vesicular distribution of PKC-K, -N, and -O was detected by
immunohistochemical analysis in the pancreatic acini from all the
experimental groups. PKC-N showed the strongest PKC
immunoreactivity (PKC-IR). In this vesicular distribution,
PKC-IR was located at the apical region of the acinar cells.
No differences were observed between control, lactating and
weaning rats. However, the immunoblot analysis of pancreatic
PKC isoforms during lactation and weaning showed a significant
translocation of PKC-N from the cytosol to the membrane
fraction when compared with control animals. Translocation of
PKC isoforms (K, N and O) in response to 12-O-tetradecanoyl
phorbol 13-acetate (TPA) 1 WM (15 min, 37³C) was comparable
in pancreatic acini from control, lactating and weaning rats. In
the control group, a significant translocation of all the isoforms
(K, N and O) from the cytosol to the membrane was observed. The
PKC isoform most translocated by TPA was PKC-N. In contrast,
no statistically significant increase in PKC-N translocation was
detected in pancreatic acini isolated from lactating or weaning
rats. These results suggest that the PKC isoforms are already
translocated to the surface of the acinar cells from lactating or
weaning rats. In addition, they suggest that isoform specific
spatial PKC distribution and translocation occur in association
with the growth response previously described in the rat exocrine
pancreas during lactation and weaning.
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1. Introduction
During pregnancy and lactation, important changes occur
in the pancreas. Hypertrophy of the pancreatic tissue is ¢rst
seen during pregnancy and sustained during lactation, fol-
lowed by hyperplasia late during the lactation period and
the ¢rst 2 weeks after weaning [1]. In addition, pancreatic
secretion is increased in lactating rats compared to control
rats [2]. Recently, a considerable amount of evidence has be-
come available supporting the role of protein kinase C (PKC)
in the regulation of pancreatic acinar secretion [3,4] and pro-
liferation [5]. However, it is not known whether the signalling
cascades involving PKC are altered during lactation and
weaning.
PKC is a family of phospholipid-dependent serine/threonine
kinases which are involved in di¡erent cell signalling systems.
To date, 12 di¡erent members have been identi¢ed and clas-
si¢ed into three groups based on their structure and cofactor
regulation: conventional PKCs (K, LI, LII and Q), novel PKCs
(N, O, R, a and W) and atypical PKCs (j, V and S). All the
isozymes require phosphatidylserine for their activation; how-
ever, only conventional PKCs are Ca2-dependent. Conven-
tional and novel PKCs are activated by diacyglycerol (DAG)
and phorbol esters [6,7]. The latter, potent tumor promoters,
can substitute for DAG in activating PKC, suggesting that
PKC plays some role in the process of neoplastic promotion
of initiated tumor cells by phorbol esters. Activation of PKC
has been proposed to be involved in a variety of cell re-
sponses, including cell proliferation, secretion, regulation of
gene expression, membrane transport and smooth muscle con-
traction [8]. PKC activity has been detected in pancreatic aci-
nar cells from several di¡erent species [4,9]. In the present
study, we were interested in the hypertrophy and hyperplasia
of pancreatic tissue that occurs during lactation and weaning
as an example of the physiological regulation of pancreatic
acinar growth. Since PKC is a key enzyme in secretory and
proliferative processes, our aim was to test the hypothesis that
pancreatic acinar proliferation and secretion that occurs dur-
ing lactation and weaning could be attributed to similarly
regulated events at the level of PKC. Since DAG has been
implicated in pancreatic acinar secretory and proliferative
processes [3,5], our attention was focused on the DAG-de-
pendent isozymes such as the K, N and O PKC isoforms [3].
To investigate the functional di¡erentiation of PKC isoforms
during lactation and weaning, we investigated the distribution
of PKC isoforms (K, N and O) in rat pancreatic acini during
lactation and weaning by immunoblot and immunohistochem-
istry using isoform-speci¢c antibodies.
2. Materials and methods
2.1. Materials
3,3P-Diaminobenzidine (DAB), PKC polyclonal antibodies (K, N
and O) and 12-O-tetradecanoyl phorbol 13-acetate (TPA) were pur-
chased from Sigma Qu|èmica (Madrid, Spain). Horseradish peroxidase
(HRP)-conjugated a¤nity-puri¢ed secondary antibody was purchased
from Chemicon International Inc. (Temecula, CA, USA). All other
agents were of the highest purity commercially available.
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2.2. Experimental animals
A population of 16 newborn female Wistar rats were selected at
birth and maintained until the age of 3 months. All animals were
allowed access to a commercial diet and drinking water ad libitum,
in a room maintained at a temperature of 20^22³C with a 12 h:12 h
light/dark schedule. At the age of 3 months, 10 female rats were
selected at random for impregnation, while the others were designated
unmated controls. The presence of spermatozoa in the vaginal smear
the following morning was regarded as evidence of impregnation. The
day of parturition was considered day 0 of lactation. Lactation was
permitted for 21 days following delivery. Eight animals (¢ve nursing
rats and three controls) were killed by decapitation after the third
week of lactation and the rest the second week after weaning, since
pancreatic tissue hyperplasia occurs late during lactation (third week
after birth) and reaches a maximum at the end of the second week
post lactation (¢fth week after birth) [1].
2.3. Preparation of pancreatic acini
Wistar rats weighing 200^250 g and fed ad libitum were killed by
decapitation. The pancreas was removed and trimmed free of fat,
connective tissue and lymph nodes. Acini were prepared using minor
modi¢cations of the technique developed by Amsterdam et al. [10]
and Esteéve et al. [11]. Krebs-Ringer medium contained 24.5 mM
HEPES, 115 mM NaCl, 4.8 mM KCl, 1.2 mM KH2PO4, 12 mM
MgSO4, 0.5 mM CaCl2, 5 mM glucose, 2 mM glutamine, 0.2%
(w/v) bovine serum albumin (BSA), 2% (v/v) essential amino acid
solution, and 1% (v/v) non-essential amino acid solution. This me-
dium was adjusted to pH 7.4 and gassed with O2+CO2. The pancreas
was injected with 4.16 ml of oxygenated Krebs-Ringer medium con-
taining 0.2 units of collagenase/ml. The distended pancreas was frag-
mented and incubated at 37³C at 60^70 oscillations/min in a shaking
water bath for 10 min. After this incubation, the medium was dis-
carded and replaced by 4.16 ml of fresh medium. The pancreas was
regassed with O2+CO2 and the incubation repeated. The tissue was
washed with Krebs-Ringer medium. Pancreatic acini were dissociated
by passing the tissue through pipettes. The acinar preparation was
puri¢ed by centrifugation for 1 min at 100Ug.
2.4. Preparation of subcellular fractions
Acini were incubated with or without TPA (1 WM) for 15 min at
37³C. The TPA concentration used in our study (1 WM) agrees with
the dose used by other authors [3,13]. Unstimulated conditions refer
to acini incubated in the absence of TPA. All of the PKC isoforms
studied showed detectable translocation with 10 nM TPA. Transloca-
tion was maximal at a TPA concentration of 1 WM and 15 min after
addition of the phorbol ester (Fig. 2). The reaction was stopped by
placing the acinar suspension on ice followed by centrifugation at
100Ug for 1 min. The pellet was resuspended in extraction bu¡er
(20 mM Tris-HCl pH 7.5, 250 mM sucrose, 6 mM EDTA, 1 mM
DTT, 1 mM PMSF, 20 Wg/ml leupeptin, 25 Wg/ml aprotinin), then
frozen and thawed twice in liquid nitrogen and a 37³C water bath.
Samples were disrupted by ultrasonication for 1 min. The suspension
was centrifuged at 100Ug for 5 min to sediment nuclei and zymogen
granules. After centrifugation at 100 000Ug for 60 min, the resulting
supernatant, referred to as the cytosolic fraction, was stored at 380³C
until use. The pellet was resuspended in extraction bu¡er containing
0.5% (v/v) Triton X-100 and extracted by agitation for 30 min at 4³C.
The suspension was then centrifuged at 100 000Ug for 60 min, and
the supernatant containing the membrane fraction was placed in ali-
quots and stored at 380³C. Aliquots of the two fractions were taken
for protein determination by the method of Bradford using BSA as a
standard [12].
2.5. Immunoblot analysis
Samples of cytosolic and membrane fractions were added to SDS
sample loading bu¡er (130 mM Tris-HCl pH 6.8, 4% SDS, 20% glyc-
erol, 10% 2-mercaptoethanol, 0.001% bromophenol blue), vortexed
and boiled for 5 min. The dose-response curves for protein amount
were checked and 25, 35 and 40 Wg of protein were chosen for PKC-K,
-N and -O analysis, respectively, according to the linear range of their
respective curves. Samples were electrophoresed in 12% SDS-poly-
acrylamide gels and then electroblotted to 0.45 Wm nitrocellulose
membranes in blotting bu¡er (25 mM Tris-HCl, pH 8.3, 192 mM
glycine, 20% methanol) overnight. The membranes were subsequently
stained with red Ponceau, washed with distilled water, cut into thin
strips and then rinsed for 5 min with TBS (20 mM Tris-HCl, pH 7.6,
137 mM NaCl). The blots were incubated at room temperature for at
least 1 h with TTBS (TBS pH 7.6, plus 0.1% (v/v) Tween-20) and 5%
dry skimmed milk to block non-speci¢c binding. The membranes were
then incubated with rabbit anti-PKC-K, -N and -O antibodies (Ab-1)
appropriately diluted in TBS (1:25 000 for anti-PKC-K and 1:10 000
for anti-PKC-N and -O) for 2 h at room temperature. After washing
once for 5 min with TTBS plus 5% dry skimmed milk and twice for
5 min with TBS, the blots were further incubated for 1 h 30 min at
room temperature with a goat anti-rabbit IgG (Ab-2) conjugated to
peroxidase-anti-peroxidase, appropriately diluted in TBS. After wash-
ing as previously described, the immunoreactive bands were visualized
by using DAB (0.12%) plus H2O2 (0.06%) dissolved in TBS. The
speci¢city of each PKC antibody (anti-PKC-K, -N or -O) was previ-
ously tested. No anti-PKC immunoreactivity (IR) was observed when
primary antibodies were removed from the assay (data not shown).
The same test was carried out for HRP-conjugated a¤nity-puri¢ed
secondary antibody and no PKC-IR was detected at that time. The
density of the bands was measured using an image analyzing system
(MIP, Microm, Spain) provided with a suitable computer program.
2.6. Immunocytochemistry
Fragments of pancreas were sectioned into 350 Wm slices and then
incubated with or without TPA (1 WM) for 15 min at 37³C. The
reaction was stopped by placing them on ice and the fragments
were ¢xed 15 min in 1.5% formaldehyde bu¡ered to pH 7.5. After
¢xation, the fragments were dehydrated in ethanol, processed for
para¤n embedding and then cut into 8 Wm thick sections.
Slides from the di¡erent experimental groups were depara¤nized.
The blockage to avoid non-speci¢c binding was carried out by incu-
bating the slides with normal goat serum (diluted 1:30 in TBS) for
30 min. Slides were then incubated with rabbit anti-PKC-K, -N and -O
antibodies (Ab-1) appropriately diluted in TBS overnight at 4³C.
After 5 min washes in TBS, the sections were incubated for 1 h
30 min at room temperature with a HRP-conjugated goat anti-rabbit
secondary antibody appropriately diluted in TBS. Peroxidase activity
was revealed with 0.12% DAB with 0.06% H2O2 for 15^20 min. Slices
were washed with distilled water, dehydrated in ethanol and mounted
on Depex. Some sections were incubated with pre-immune serum at
1:30 dilution as the primary antiserum, others were incubated only
with DAB (neither primary nor secondary antibodies); these control
sections showed no immunoreactive product (data not shown). The
analysis of the immunostained sections was carried out by capturing
the image with a microscope coupled to a video camera.
2.7. Data analysis
Statistical comparisons of the immunoblotting data were analyzed
by ANOVA and the Newman-Keuls t-test. Means among groups were
considered signi¢cantly di¡erent when the P value was less than 0.05.
3. Results
A vesicular distribution of PKC-IR was detected for the K,
N and O PKC isoforms in pancreatic acini from control, lactat-
ing and weaning rats. In this vesicular distribution, PKC-IR
was located in the apical pole of the acinar cells. No di¡er-
ences in its distribution were observed during lactation or
weaning compared with their respective controls. PKC-N
showed the strongest immunoreactivity. Incubation of the
pancreatic fragments with 1 WM TPA showed a di¡use cyto-
plasmic distribution of the immunostaining in control, lactat-
ing and weaning rats (Fig. 1).
Western blot analyses were performed to con¢rm the spe-
ci¢city of the antibodies and to examine the localization of
PKC isoforms in subcellular fractions (data not shown). In
each case, only one major band was detected that was not
observed in the absence of the primary antibody. Similar ex-
periments performed in the absence of the anti-rabbit secon-
dary antibody showed no PKC-IR (data not shown).
Fig. 2 illustrates a representative immunoblot of PKC-K
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distribution in pancreatic acini. Similar results were observed
for PKC-N and -O. In control acini, 30^35% of each isoform
was associated with the membrane fraction.
Lactation and weaning led to PKC-N translocation from the
cytosol to the membrane. This translocation was higher at the
late lactation period than at 2 weeks after weaning (Fig. 3).
This e¡ect was not observed, however, for PKC-K or PKC-O.
To determine whether the change in PKC-N distribution in
pancreatic acini during lactation and weaning as compared
with control animals could be due to an active translocation,
the e¡ect of TPA stimulation was also examined. Therefore,
we studied the e¡ect of TPA on the distribution of the PKC
isoforms (K, N and O) in cytosol and membranes of pancreatic
acini from control animals (Fig. 3).
The e¡ect of TPA on the translocation of these PKC iso-
forms was dose-dependent. When pancreatic acini were incu-
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Fig. 2. Left panel: E¡ect of TPA on PKC-K distribution in cytosolic (C) and membrane (M) fractions from pancreatic acini. Acini were incu-
bated with 1 WM TPA at 37³C for the indicated periods of time. PKC-K distribution was subsequently determined in membrane and cytosolic
fractions by immunoblotting. The results are expressed as a percentage of the total amount of isoform present in both fractions. Results given
are the means from three separate experiments. Right panel: Representative immunoblot analysis of PKC-K distribution in cytosol and mem-
brane fractions of pancreatic acini incubated with TPA. Pancreatic acini were incubated with 1 WM TPA for 15 min at 37³C and the cytosolic
and membrane fractions were subsequently analyzed for PKC-K immunoreactivity. The numbers on the left of the strips refer to the position
of the molecular weight markers.
Fig. 1. Sections from rat pancreas immunostained with a rabbit polyclonal antibody against PKC-N. Sections from control (a) and lactating (c)
rat pancreas without TPA stimulation show vesicular staining for PKC-N, predominantly localized to the apical pole of the acinar cells. Sec-
tions from control (b) and lactating (d) rat pancreas after TPA stimulation show a redistribution of PKC-immunoreactivity (PKC-IR) for
PKC-N (U404).
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bated with 10 nM TPA at 37³C, a detectable translocation
occurred. Increasing TPA concentrations induced an increase
in this translocation, reaching a maximum at the highest dose
tested (1 WM) (data not shown). The TPA-induced PKC-K,
PKC-N and PKC-O translocation was also time-dependent.
Fig. 2 shows the immunoblot analysis for PKC-K. The TPA
(1 WM) time course study revealed a time-dependent increase
of PKC-K in the membrane fraction, with a maximum at
15 min after addition of TPA to the incubation medium. At
this time period, a decrease in the cytosolic fraction was ob-
served. Similar results were obtained for the PKC-N and PKC-
O isoforms in control rat pancreatic acini (data not shown).
4. Discussion
This study demonstrates the presence of the PKC isoforms-
K, -N and -O in pancreatic acini from control, lactating and
weaning rats. The immunohistochemical results demonstrate a
vesicular distribution of PKC-K, -N and -O in acinar cells.
These three isoforms are present in the apical region of these
cells. The detection of PKC-O in the apical region of pancre-
atic acinar cells agrees with a previous study reported by
others [13]. However, our study also detected the presence
of PKC-K and -N as opposed to the previously cited study.
These di¡erences may re£ect the use of di¡erent antisera. The
relationship of PKC with vesicles has previously been demon-
strated [14,15] and it has been reported that PKC activity is
essential for the formation of constitutive transport vesicles at
the trans-Golgi network (TGN) [16,17]. In fact, PKC inhib-
itors prevent vesicle generation [18] ; however, phorbol ester-
induced PKC activation has been shown to induce vesicle
accumulation [19] by inhibiting exocytosis [20]. This vesicle
accumulation could be related to PKC-dependent annexin II
phosphorylation [21]. Taking all this into account, it seems
obvious that PKC plays an important role in the regulation
of exocytosis, as has been previously suggested [22]. The
present study shows a vesicular pattern for PKC-K, -N and
-O. In addition, redistribution of PKC in the acinar cells is
observed after TPA treatment. This redistribution may be
due to an increase in vesicular synthesis and/or to changes
in vesicular distribution. Because of the high amount of
PKC associated with vesicles, the activation of cytosolic
PKC may have only a marginal e¡ect on this PKC-IR redis-
tribution. In this sense, one may to hypothesize the existence
of two di¡erent pools of PKC in pancreatic acinar cells, one
constitutively bound to the membrane fraction (to the
vesicles) and the other susceptible to translocation. In agree-
ment with this idea, it was not possible to detect a 100%
translocation because there is always PKC in the particulate
(membrane) fraction. However, it must be noted that, for
immunoblotting studies, zymogen granules (vesicles) were
eliminated. In this case, redistribution could be due to vesicle
accumulation and disorganization.
It is generally thought that the cellular distribution of PKC
re£ects the biological activity of the enzyme [23]. In the resting
cells, PKC is usually localized in the cytosol as an inactive
form. Upon stimulation of the cell, the enzyme is activated
and generally translocated to a particulate fraction. In this
study, immunocytochemical analysis showed that lactation
and weaning leads to PKC-N translocation from the cytosol
to the membrane of pancreatic acini. This distribution of
PKC-N in the pancreatic acinar cell of lactating and weaning
rats might be a unique sort of PKC translocation or may
simply be due to the fact that the amount of PKC-N expressed
in these acinar cells is greater than that expressed in control
cells. This apparent sustained translocation of PKC-N might
be due to endocrine changes that occur during lactation and
weaning.
If endocrine factors are the cause of physiological changes
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Fig. 3. Top panel: Representative immunoblot analysis of PKC-N in
pancreatic acini from control (CT), lactating (L) and weaning (W)
rats. Acini were incubated for 15 min at 37³C with (stimulated) or
without (unstimulated) 1 WM TPA and PKC-N was then determined
in cytosolic (C) and membrane (M) fractions by immunoblotting.
Bottom panel: E¡ect of in vitro TPA on the distribution of PKC-N,
-K and -O in membrane fractions of pancreatic acini isolated from
control, lactating and weaning rats. Cytosol and membrane frac-
tions were isolated and assayed for PKC immunoblot analysis as
described in Section 2. Results given are the means from three sepa-
rate experiments. Statistical comparison vs. unmated females:
*P6 0.05, **P6 0.01.
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of the exocrine pancreas during lactation, several possible
hormones could be responsible for the results obtained. Lac-
tation is a condition associated with elevated prolactin levels
[24]. An enhancement of cell proliferation by hyperprolactine-
mia has been described in the exocrine pancreas [25]. In addi-
tion, prolactin signi¢cantly increases total PKC activity [26].
Several lines of evidence suggest that cholecystokinin and gas-
trin are also trophic factors in the pancreas [27]. In addition,
plasma levels of these two hormones are increased during
lactation [28]. Both hormones also increase total PKC activity
[29,30]. Therefore, these endocrine changes could explain, at
least in part, the increase of PKC-N translocation detected
during lactation and weaning. Changes in PKC activity and
subcellular distribution have also been described during lacta-
tion in rat mammary tissue [31^33].
The ¢nding that PKC-N was apparently translocated in a
sustained chronic manner was rather surprising, given the fact
that prolonged activation with phorbol esters generally leads
to down-regulation and depletion of PKC from the cells
[9,34]. However, Assert et al. [35] have recently shown an
up-regulation of PKC-N by phorbol esters in human T84 cells.
Our present ¢nding that TPA can induce translocation of
PKC isoforms from the cytosol to the membrane fraction in
pancreatic acini agrees with previous ¢ndings by others [3,36].
The fact that a statistically signi¢cant TPA-induced PKC-N
translocation was not detectable in pancreatic acini from lac-
tating and weaning rats in contrast to control rats suggests
that PKC-N is already translocated to the membrane in pan-
creatic acini from lactating and weaning rats. In view of the
antiproliferative e¡ects of PKC-N in several cell types [37^39],
its sustained translocation may thus represent a protective
mechanism against proliferative e¡ects caused by cellular
overactivation.
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